Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
243 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00607724 | GDC-0449 in Treating Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 68 | Genentech, Inc.INDUSTRY | 0 | Oct 8, 2015 | clinicaltrials |
| NCT00932373 | A Study of Trastuzumab-MCC-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer Who Have Previously Received a Trastuzumab-Containing Regimen | completed | Phase 1 | 54 | Genentech, Inc.INDUSTRY | 0 | Aug 26, 2015 | clinicaltrials |
| NCT01160250 | A Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma | approved for marketing | — | — | Genentech, Inc.INDUSTRY | 1 | Aug 6, 2015 | clinicaltrials |
| NCT00027027 | Safety Study of rhuMAb 2C4 to Treat Advanced Solid Tumors | completed | Phase 1 | 21 | Genentech, Inc.INDUSTRY | 1 | Jul 27, 2015 | clinicaltrials |
| NCT00063154 | Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy | completed | Phase 2 | 51 | Genentech, Inc.INDUSTRY | 1 | Jul 7, 2015 | clinicaltrials |
| NCT00109265 | A Study to Evaluate Erlotinib in Patients With Advanced or Metastatic Breast Cancer During or Following Chemotherapy | completed | Phase 2 | — | Genentech, Inc.INDUSTRY | 0 | Jul 2, 2015 | clinicaltrials |
| NCT00058539 | Safety and Efficacy Study of Pertuzumab to Treat Castration-Resistant Prostate Cancer | completed | Phase 2 | 42 | Genentech, Inc.INDUSTRY | 0 | Jun 23, 2015 | clinicaltrials |
| NCT00096941 | A Study to Evaluate Subjects Treated With rhuMab 2C4 (Pertuzumab) in a Previous Genentech Phase II Cancer Study | completed | Phase 2 | 3 | Genentech, Inc.INDUSTRY | 0 | Jun 11, 2015 | clinicaltrials |
| NCT00096993 | A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | completed | Phase 2 | 131 | Genentech, Inc.INDUSTRY | 1 | Jun 10, 2015 | clinicaltrials |
| NCT01201915 | A Study Evaluating the Efficacy and Safety of Vismodegib (GDC-0449) in Operable Basal Cell Carcinoma | completed | Phase 2 | 74 | Genentech, Inc.INDUSTRY | 1 | Jun 24, 2014 | clinicaltrials |
| NCT00109239 | A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast Cancer | completed | Phase 3 | — | Genentech, Inc.INDUSTRY | 0 | Jun 18, 2014 | clinicaltrials |
| NCT00081614 | A Study Evaluating Tarceva in Combination With Avastin Versus Avastin Alone in Treating Metastatic Renal Cell Carcinoma | completed | Phase 2 | 100 | Genentech, Inc.INDUSTRY | 1 | May 16, 2014 | clinicaltrials |
| NCT00109226 | A Study to Evaluate Avastin in Combination With Chemotherapy in Patients With Metastatic Colorectal Cancer | completed | Phase 2 | — | Genentech, Inc.INDUSTRY | 0 | Apr 8, 2014 | clinicaltrials |
| NCT00096967 | A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study | completed | Phase 3 | 100 | Genentech, Inc.INDUSTRY | 0 | Mar 26, 2014 | clinicaltrials |
| NCT00556699 | A Study of SGN-40 in Combination With Rituximab in Patients With CD20-Positive, Follicular and Marginal Zone B-Cell Non-Hodgkin's Lymphoma | completed | Phase 1 | 22 | Genentech, Inc.INDUSTRY | 0 | Mar 20, 2014 | clinicaltrials |
| NCT00091663 | A Study to Evaluate Tarceva in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) | completed | Phase 3 | 5,000 | Genentech, Inc.INDUSTRY | 1 | Mar 4, 2014 | clinicaltrials |
| NCT00337883 | A Study of the Safety and Efficacy of Tarceva in Patients With First Relapse of Grade IV Glioma (Glioblastoma Multiforme) | completed | Phase 2 | 110 | Genentech, Inc.INDUSTRY | 0 | Mar 4, 2014 | clinicaltrials |
| NCT00262067 | A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1) | unknown | Phase 3 | 1,237 | Genentech, Inc.INDUSTRY | 22 | Dec 13, 2013 | clinicaltrials |
| NCT00005635 | Trastuzumab Plus Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2 | completed | Phase 2 | — | Genentech, Inc.INDUSTRY | 1 | Aug 20, 2013 | clinicaltrials |
| NCT00281697 | A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2) | completed | Phase 3 | 684 | Genentech, Inc.INDUSTRY | 0 | Jul 26, 2013 | clinicaltrials |
| NCT00047736 | A Study With Tarceva and Chemotherapy vs. Chemotherapy Alone in Patients With Advanced Lung Cancer | completed | Phase 3 | — | Genentech, Inc.INDUSTRY | 1 | Jun 21, 2013 | clinicaltrials |
| NCT00109057 | An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study | completed | Phase 2 | 56 | Genentech, Inc.INDUSTRY | 0 | Jun 21, 2013 | clinicaltrials |
| NCT00109070 | A Study to Evaluate Avastin in Combination With Standard Chemotherapy to Treat Colorectal Cancer | completed | Phase 3 | — | Genentech, Inc.INDUSTRY | 0 | Jun 21, 2013 | clinicaltrials |
| NCT00855894 | A Study of the Combination of Erlotinib and Pertuzumab in Patients With Relapsed Non-small Cell Lung Cancer(PENGUIN) | completed | Phase 2 | 41 | Genentech, Inc.INDUSTRY | 2 | May 21, 2013 | clinicaltrials |
| NCT00509769 | A Study of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) Administered Intravenously to Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer | completed | Phase 2 | 112 | Genentech, Inc.INDUSTRY | 1 | Apr 2, 2013 | clinicaltrials |
| NCT00097578 | A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma | completed | — | 1,953 | Genentech, Inc.INDUSTRY | 1 | Mar 28, 2013 | clinicaltrials |
| NCT00452127 | A Trial of the Safety of Escalating Doses of PRO131921 in Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma | terminated | Phase 1 / Phase 2 | 26 | Genentech, Inc.INDUSTRY | 0 | Jan 28, 2013 | clinicaltrials |
| NCT00400764 | A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas | terminated | Phase 1 / Phase 2 | 72 | Genentech, Inc.INDUSTRY | 0 | Nov 23, 2011 | clinicaltrials |
| NCT00403403 | A Study of Bevacizumab in Previously Untreated Extensive-Stage Small Cell Lung Cancer (SALUTE) | completed | Phase 2 | 102 | Genentech, Inc.INDUSTRY | 0 | Apr 29, 2011 | clinicaltrials |
| NCT00747734 | A Study of MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors | completed | Phase 1 | 35 | Genentech, Inc.INDUSTRY | 0 | Apr 20, 2011 | clinicaltrials |
| NCT00318136 | A Study of Bevacizumab Plus Carboplatin and Paclitaxel in Subjects With Advanced, Previously Untreated, Squamous Non-Small Cell Lung Cancer (BRIDGE) | completed | Phase 2 | 47 | Genentech, Inc.INDUSTRY | 0 | May 11, 2010 | clinicaltrials |
| NCT00105456 | A Study of Patients With HER2-Positive Metastatic Breast Cancer | completed | — | 1,000 | Genentech, Inc.INDUSTRY | 0 | May 6, 2010 | clinicaltrials |
| NCT00434356 | A Study of Sunitinib in Combination With Bevacizumab and Paclitaxel in Previously Untreated Patients With Metastatic Breast Cancer (SABRE-B) | terminated | Phase 2 | 46 | Genentech, Inc.INDUSTRY | 0 | Dec 3, 2009 | clinicaltrials |
| NCT00434226 | A Study of Sunitinib in Combination With Bevacizumab, Carboplatin, and Paclitaxel in Patients With Advanced Non-Small Cell Lung Cancer (SABRE-L) | terminated | Phase 2 | 56 | Genentech, Inc.INDUSTRY | 0 | Aug 21, 2009 | clinicaltrials |
| NCT00491738 | A Study Evaluating the Efficacy and Safety of Sunitinib With or Without Bevacizumab in First-Line Patients With Metastatic Renal Cell Cancer (SABRE-R) | terminated | Phase 2 | 16 | Genentech, Inc.INDUSTRY | 0 | Apr 10, 2009 | clinicaltrials |
| NCT00272415 | A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With Melanoma | terminated | Phase 1 | 39 | Genentech, Inc.INDUSTRY | 0 | Mar 11, 2009 | clinicaltrials |
| NCT00753480 | A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | suspended | Phase 1 | 56 | Genentech, Inc.INDUSTRY | 1 | Nov 7, 2008 | clinicaltrials |
| NCT00095225 | A Study to Evaluate Bevacizumab and Chemotherapy or Tarceva in Treating Recurrent or Refractory NSCLC (Non-Small Cell Lung Cancer) | completed | Phase 2 | 122 | Genentech, Inc.INDUSTRY | 1 | Jan 29, 2008 | clinicaltrials |
| NCT00114946 | A Study to Compare Two Avastin-Based Treatment Regimens for the Treatment of Metastatic Colorectal Cancer | terminated | Phase 4 | 800 | Genentech, Inc.INDUSTRY | 0 | May 29, 2006 | clinicaltrials |
| NCT00047762 | Safety, Efficacy, and Pharmacokinetics Study of Tarceva to Treat Advanced Colorectal Cancer | completed | Phase 1 | — | Genentech, Inc.INDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials